Search results
EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer
Pharmaceutical Technology via Yahoo Finance· 16 hours agoPatients in the trial received 80mg of Tagrisso once daily, along with pemetrexed and a choice of...
Perioperative Chemo Extends Survival in Resectable Esophageal Cancer
MedPage Today· 2 days agoOS rates in the two treatment arms, respectively, were 57.4% and 50.7% at 3 years, and 50.6% and...
ASCO24: Akeso’s bispecific vvonescimab faces a rocky road ahead in NSCLC
Pharmaceutical Technology via Yahoo Finance· 3 days agoCompared to the chemotherapy control, ivonescimab plus...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 5 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
Cullinan Therapeutics announces success for zipalertinib as combo therapy
Clinical Trials Arena via Yahoo Finance· 2 days agoEGFR is overexpressed in tumour cells and involved in cell proliferation. Johnson & Johnson’s...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 2 days agoThe therapy was evaluated as a monotherapy and in combination with AbbVie’s investigative programmed...
First results from late-breaking Phase 3 PALOMA-3 study show five-fold reduction in infusion-related...
telegraphherald.com· 4 days agoJohnson & Johnson announced today first data from the Phase 3 PALOMA-3 study evaluating subcutaneous (SC) amivantamab combined with lazertinib in patients with locally advanced or metastatic ...
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 7 days agoParticipants were assigned in a 2:1 ratio to receive either KEYTRUDA with chemotherapy or a...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 1 day agoLate-breaking results from PALOMA-2 study of subcutaneous amivantamab in combination with lazertinib show clinically meaningful antitumor response and improved safety profile in patients with ...
Carefully Designing De-escalation Trials in Breast Cancer
Medscape· 6 days agoDe-escalation trials in early breast cancer are "critical to preserving quality of life" but require...